Significance of the anti-aging protein Klotho

Molecular Membrane Biology

Volumn 30, Issue 8, 2013, Pages 369-385

  Dërmaku Sopjani, Miribane ^a   Kolgeci, Selim ^a   Abazi, Sokol ^b   Sopjani, Mentor ^a  

^a UNIVERSITY OF PRISHTINA   (Serbia)

^b UNIVERSITY OF TIRANA   (Albania)

Author keywords

Aging; Calcium homeostasis; Fibroblast growth factor; Klotho; Parathyroid hormone (PTH); Phosphate; Vitamin D

Indexed keywords

CALCIUM; CALCIUM CHANNEL; CELL SURFACE RECEPTOR; DENTIN MATRIX PROTEIN 1; FIBROBLAST GROWTH FACTOR 23; HUMORAL ANTIBODY; INSULIN; KLOTHO PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PARATHYROID HORMONE; PHOSPHATE; PROTEIN SHC; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM PHOSPHATE COTRANSPORTER 2; SOMATOMEDIN C; STAT1 PROTEIN; VANILLOID RECEPTOR 5; VITAMIN D;

AGING; ANTIOXIDANT ACTIVITY; AUTOPHOSPHORYLATION; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; DEGLYCOSYLATION; DOWN REGULATION; GLUCOSE METABOLISM; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PARATHYROID HORMONE RELEASE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; STEADY STATE;

AGING; ANIMALS; CALCIUM; CELL PROLIFERATION; CELL SURVIVAL; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HOMEOSTASIS; HUMANS; KIDNEY DISEASES; MEMBRANE PROTEINS; MICE; NEOPLASM METASTASIS; NEOPLASMS; PHOSPHATES; SIGNAL TRANSDUCTION; VASCULAR CALCIFICATION;

EID: 84888594511     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.3109/09687688.2013.837518     Document Type: Review

References (134)

1. Aizawa H, Saito Y, Nakamura T, et al. 1998. Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats. Biochem Biophys Res Commun 249:865-871. (Pubitemid 28441930)
2. Alexander RT, Woudenberg-Vrenken TE, Buurman J, et al. 2009. Klotho prevents renal calcium loss. J Am Soc Nephrol 20:2371-2379.
3. Amato D, Maravilla A, Montoya C, et al. 1998. Acute effects of soft drink intake on calcium and phosphate metabolism in immature and adult rats. Rev Invest Clin 50:185-189. (Pubitemid 128548932)
4. AndrukhovaO, ZeitzU, GoetzR, et al. 2012. FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2-SGK1 signaling pathway. Bone 51:621-628.
5. Anour R, Andrukhova O, Ritter E, et al. 2012. Klotho lacks a vitamin D independent physiological role in glucose homeosta-sis, bone turnover, and steady-state PTH secretion in vivo. PLoS ONE 7:e31376.
6. Arai E, Kanai Y, Ushijima S, et al. 2006. Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues. Int J Cancer 119:288-296.
7. Bai X, Miao D, Li J, et al. 2004. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 145:5269-5279. (Pubitemid 39551149)
8. Bergwitz C, Juppner H. 2010. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61:91-104.
9. Berndt T, Kumar R. 2009. Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda) 24:17-25.
10. Bhandaru M, Kempe DS, Rotte A, et al. 2011. Decreased bone density and increased phosphaturia in gene-targeted mice lacking functional serum-and glucocorticoid-inducible kinase 3. Kidney Int 80:61-67.
11. Blaine J, Weinman EJ, Cunningham R. 2011. The regulation of renal phosphate transport. Adv Chronic Kidney Dis 18:77-84.
12. Camilli TC, Xu M, O'Connell MP, et al. 2011. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility. Pigment Cell Melanoma Res 24:175-186.
13. Cannata-Andia JB, Rodriguez GM, Gomez AC. 2012. Osteoporosis and adynamic bone in chronic kidney disease. J Nephrol 26 (1):73-80.
14. Cha SK, Ortega B, Kurosu H, et al. 2008. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci USA 105:9805-9810. (Pubitemid 352031381)
15. Chang Q, Hoefs S, van der Kemp AW, et al. 2005. The beta-glu-curonidase klotho hydrolyzes and activates the TRPV5 channel. Science 310:490-493. (Pubitemid 41507962)
16. Chen B, Ma X, Liu S, et al. 2012. Inhibition of lung cancer cells growth, motility and induction of apoptosis by Klotho, a novel secreted Wnt antagonist, in a dose-dependent manner. Cancer Biol Ther 13:1221-1228.
17. Chen CD, Podvin S, Gillespie E, et al. 2007. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci USA 104:19796-19801.
18. Chen L, Liu H, Liu J, et al. 2013. Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma. PLoS ONE 8:e58413.
19. Corut A, Senyigit A, Ugur SA, et al. 2006. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 79:650-656. (Pubitemid 44452742)
20. Deanfield JE, Halcox JP, Rabelink TJ. 2007. Endothelial function and dysfunction: Testing and clinical relevance. Circulation 115:1285-1295. (Pubitemid 46594773)
21. Dermaku-Sopjani M, Sopjani M, Saxena A, et al. 2011. Down-regulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cell Physiol Biochem 28:251-258.
22. Di Marco GS, Hausberg M, Hillebrand U, et al. 2008. Increased inorganic phosphate induces human endothelial cell apoptosis in vitro. Am J Physiol Renal Physiol 294:F1381-F1387.
23. Doi S, Zou Y, Togao O, et al. 2011. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem 286:8655-8665.
24. Faul C, Amaral AP, Oskouei B, et al. 2011. FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393-4408.
25. Foller M, Kempe DS, Boini KM, et al. 2011. PKB/SGK-resistant GSK3 enhances phosphaturia and calciuria. J Am Soc Nephrol 22:873-880.
26. Franco R, Schoneveld O, Georgakilas AG, et al. 2008. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 266:6-11.
27. Fukumoto S, Yamashita T. 2002. Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin. Curr Opin Nephrol Hypertens 11:385-389. (Pubitemid 34734616)
28. Gattineni J, Bates C, Twombley K, et al. 2009. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypopho-sphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol 297:F282-F291.
29. Gattineni J, Baum M. 2010. Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): Implications for disorders of phosphate metabolism. Pediatr Nephrol 25:591-601.
30. Grosskopf I, Graff E, Charach G, et al. 1991. Hyperphosphataemia and hypocalcaemia induced by hypertonic phosphate enema-an experimental study and review of the literature. Hum Exp Toxicol 10:351-355.
31. Haraikawa M, Tanabe R, Sogabe N, et al. 2012. A study of the association between serum bone-specific alkaline phosphatase and serum phosphorus concentration or dietary phosphorus intake. J Nutr Sci Vitaminol (Tokyo) 58:442-445.
32. Haruna Y, Kashihara N, Satoh M, et al. 2007. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci USA 104:2331-2336. (Pubitemid 46391397)
33. Hattenhauer O, Traebert M, Murer H, et al. 1999. Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake. Am J Physiol 277:G756-G762. (Pubitemid 29525926)
34. Haussler MR, Whitfield GK, Kaneko I, et al. 2012. The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis. Rev Endocr Metab Disord 13:57-69.
35. Ho HK, Pok S, Streit S, et al. 2009. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fe-toprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. J Hepatol 50:118-127.
36. Hsieh CC, Kuro-o M, Rosenblatt KP, et al. 2010. The ASK1-Signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of aging. Aging (Albany NY) 2:597-611.
37. Hu MC, Shi M, Zhang J, et al. 2010a. Klotho: A novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24:3438-3450.
38. Hu MC, Shi M, Zhang J, et al. 2011. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22:124-136.
39. Hu MC, Shi M, Zhang J, et al. 2010b. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int 78:1240-1251.
40. Ichikawa S, Imel EA, Kreiter ML, et al. 2007. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 117:2684-2691. (Pubitemid 47494368)
41. Ikushima M, Rakugi H, Ishikawa K, et al. 2006. Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem Biophys Res Commun 339:827-832. (Pubitemid 41772888)
42. Imai M, Ishikawa K, Matsukawa N, et al. 2004. Klotho protein activates the PKC pathway in the kidney and testis and suppresses 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression. Endocrine 25:229-234. (Pubitemid 41271125)
43. Imura A, Tsuji Y, Murata M, et al. 2007. Alpha-Klotho as a regulator of calcium homeostasis. Science 316:1615-1618.
44. Itoh N, Ornitz DM. 2004. Evolution of the Fgf and Fgfr gene families. Trends Genet 20:563-569. (Pubitemid 39314564)
45. Jin H, Xu CX, Lim HT, et al. 2009. High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling. Am J Respir Crit Care Med 179:59-68.
46. John GB, Cheng CY, Kuro-o M. 2011. Role of Klotho in aging, phosphate metabolism, and CKD. Am J Kidney Dis 58:127-134.
47. Jones G, Prosser DE, Kaufmann M. 2012. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin D. Arch Biochem Biophys 523:9-18.
48. Katai K, Miyamoto K, Kishida S, et al. 1999. Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1, 25-dihydroxyvitamin D3. Biochem J 343 (Pt 3):705-712. (Pubitemid 29537385)
49. Kempe DS, Ackermann TF, Fischer SS, et al. 2009. Accelerated suicidal erythrocyte death in Klotho-deficient mice. Pflugers Arch 458:503-512.
50. Kempe DS, Dermaku-Sopjani M, Frohlich H, et al. 2010. Rapa-mycin-induced phosphaturia. Nephrol Dial Transplant 25:2938-2944.
51. Koh N, Fujimori T, Nishiguchi S, et al. 2001. Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 280:1015-1020. (Pubitemid 32924441)
52. Kops GJ, Dansen TB, Polderman PE, et al. 2002. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419:316-321.
53. Kuro O. 2011. Phosphate and Klotho. Kidney Int Suppl S20-S23.
54. Kuro O. 2012. Klotho in health and disease. Curr Opin Nephrol Hypertens 21:362-368.
55. Kuro-o M. 2010. Klotho. Pflugers Arch 459:333-343.
56. Kuro-o M, Matsumura Y, Aizawa H, et al. 1997. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51. (Pubitemid 27494749)
57. Kurosu H, Choi M, Ogawa Y, et al. 2007. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 282:26687-26695. (Pubitemid 47501965)
58. Kurosu H, Ogawa Y, Miyoshi M, et al. 2006. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281:6120-6123. (Pubitemid 43847540)
59. Kurosu H, Yamamoto M, Clark JD, et al. 2005. Suppression of aging in mice by the hormone Klotho. Science 309:1829-1833. (Pubitemid 41325087)
60. Kuznetsov SA, Mankani MH, Robey PG. 2000. Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation. Transplantation 70:1780-1787. (Pubitemid 32064834)
61. Larsson T, Marsell R, Schipani E, et al. 2004. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145:3087-3094. (Pubitemid 38829975)
62. Lee J, Jeong DJ, Kim J, et al. 2010. The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma. Mol Cancer 9:109.
63. Li BS, Ma HX, Wang YJ, et al. 2012. [Klotho gene attenuates the progression of hypertension and heart damage in spontaneous hypertensive rats]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 29:662-668.
64. Lim K, Lu TS, Molostvov G, et al. 2012. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 125:2243-2255.
65. Lin BC, Wang M, Blackmore C, et al. 2007. Liver-specific activities of FGF19 require Klotho beta. J Biol Chem 282:27277-27284. (Pubitemid 47501977)
66. Liu H, Fergusson MM, Castilho RM, et al. 2007. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317:803-806. (Pubitemid 47257917)
67. Liu S, Guo R, Simpson LG, et al. 2003. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278:37419-37426. (Pubitemid 37175262)
68. Liu S, Zhou J, Tang W, et al. 2006. Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab 291:E38-E49. (Pubitemid 44035308)
69. Liu S, Zhou J, Tang W, et al. 2008. Pathogenic role of Fgf23 in Dmp1-null mice. Am J Physiol Endocrinol Metab 295:E254-E261.
70. Lotscher M, Kaissling B, Biber J, et al. 1997. Role of microtubules in the rapid regulation of renal phosphate transport in response to acute alterations in dietary phosphate content. J Clin Invest 99:1302-1312. (Pubitemid 27142768)
71. Lu P, Boros S, Chang Q, et al. 2008. The beta-glucuronidase klotho exclusively activates the epithelial Ca2+ channels TRPV5 and TRPV6. Nephrol Dial Transplant 23:3397-3402.
72. Maekawa Y, Ishikawa K, Yasuda O, et al. 2009. Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine 35:341-346.
73. Manya H, Akasaka-Manya K, Endo T. 2010. Klotho protein deficiency and aging. Geriatr Gerontol Int 10(Suppl 1):S80-S87.
74. Martin A, David V, Quarles LD. 2012. Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 92:131-155.
75. Matsumura Y, Aizawa H, Shiraki-Iida T, et al. 1998. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun 242:626-630. (Pubitemid 28412578)
76. Mitobe M, Yoshida T, Sugiura H, et al. 2005. Oxidative stress decreases klotho expression in a mouse kidney cell line. Neph-ron Exp Nephrol 101:e67-e74. (Pubitemid 41208903)
77. Mizobuchi M, Hatamura I, Ogata H, et al. 2004. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. J Am Soc Nephrol 15:2579-2587. (Pubitemid 41103364)
78. Moreno JA, Izquierdo MC, Sanchez-Nino MD, et al. 2011. The inflammatory cytokines TWEAK and TNFalpha reduce renal klotho expression through NFkappaB. J Am Soc Nephrol 22:1315-1325.
79. Murer H, Biber J. 2010. Phosphate transport in the kidney. J Nephrol 23(Suppl 16):S145-S151.
80. Murshed M, Harmey D, Millan JL, et al. 2005. Unique coexpres-sion in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19:1093-1104. (Pubitemid 40632454)
81. Nagai R, Saito Y, Ohyama Y, et al. 2000. Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell Mol Life Sci 57:738-746. (Pubitemid 30392032)
82. Nowik M, Picard N, Stange G, et al. 2008. Renal phosphaturia during metabolic acidosis revisited: Molecular mechanisms for decreased renal phosphate reabsorption. Pflugers Arch 457:539-549.
83. Ohnishi M, Nakatani T, Lanske B, et al. 2009. Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 75:1166-1172.
84. Ohnishi M, Razzaque MS. 2010. Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 24:3562-3571.
85. Osuka S, Razzaque MS. 2012. Can features of phosphate toxicity appear in normophosphatemia? J Bone Miner Metab 30:10-18.
86. Perwad F, Zhang MY, Tenenhouse HS, et al. 2007. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxy-lase expression in vitro. Am J Physiol Renal Physiol 293:F1577-F1583. (Pubitemid 350085994)
87. Poh W, Wong W, Ong H, et al. 2012. Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth receptor-4 signaling in hepatocellular carcinoma. Mol Cancer 11:14.
88. Quarles LD. 2012. Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease. Exp Cell Res 318:1040-1048.
89. Quyyumi AA. 1998. Endothelial function in health and disease: New insights into the genesis of cardiovascular disease. Am J Med 105:32S-39S. (Pubitemid 28364424)
90. Rakugi H, Matsukawa N, Ishikawa K, et al. 2007. Anti-oxidative effect of Klotho on endothelial cells through cAMP activation. Endocrine 31:82-87. (Pubitemid 350194199)
91. Razzaque MS, Sitara D, Taguchi T, et al. 2006. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 20:720-722. (Pubitemid 46671193)
92. Rodriguez ME, Almaden Y, Canadillas S, et al. 2007. The calci-mimetic R-568 increases vitamin D receptor expression in rat parathyroid glands. Am J Physiol Renal Physiol 292:F1390-F1395. (Pubitemid 46701865)
93. Sabbagh Y, Giral H, Caldas Y, et al. 2011. Intestinal phosphate transport. Adv Chronic Kidney Dis 18:85-90.
94. Sabbagh Y, O'Brien SP, Song W, et al. 2009. Intestinal npt2b plays a major role in phosphate absorption and homeostasis. J Am Soc Nephrol 20:2348-2358.
95. Saito Y, Nakamura T, Ohyama Y, et al. 2000. In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun 276:767-772.
96. Satoh M, Nagasu H, Morita Y, et al. 2012. Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling. Am J Physiol Renal Physiol 303:F1641-F1651.
97. Segawa H, Yamanaka S, Ohno Y, et al. 2007. Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. Am J Physiol Renal Physiol 292:F769-F779. (Pubitemid 46220545)
98. Semba RD, Cappola AR, Sun K, et al. 2011a. Plasma klotho and cardiovascular disease in adults. J Am Geriatr Soc 59:1596-1601.
99. Semba RD, Cappola AR, Sun K, et al. 2011b. Plasma klotho and mortality risk in older community-dwelling adults. J Gerontol A Biol Sci Med Sci 66:794-800.
100. Shimada T, Takeshita Y, Murohara T, et al. 2004a. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 110:1148-1155. (Pubitemid 39328204)
101. Shimada T, Urakawa I, Yamazaki Y, et al. 2004b. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 314:409-414. (Pubitemid 38084732)
102. Shimamura Y, Hamada K, Inoue K, et al. 2012. Serum levels of soluble secreted alpha-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Clin Exp Nephrol 16(5):722-729.
103. Shimizu H, Bolati D, Adijiang A, et al. 2011. Indoxyl sulfate downregulates renal expression of Klotho through production of ROS and activation of nuclear factor-kB. Am J Nephrol 33:319-324.
104. Sitara D, Kim S, Razzaque MS, et al. 2008. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet 4:e1000154.
105. Sitara D, Razzaque MS, Hesse M, et al. 2004. Homozygous ablation of fibroblast growth factor-23 results in hyperphospha-temia and impaired skeletogenesis, and reverses hypophospha-temia in Phex-deficient mice. Matrix Biol 23:421-432. (Pubitemid 39576657)
106. Sitara D, Razzaque MS, St Arnaud R, et al. 2006. Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol 169:2161-2170. (Pubitemid 351181975)
107. Sopjani M, Alesutan I, Dermaku-Sopjani M, et al. 2011. Regulation of the Na+/K+ ATPase by Klotho. FEBS Lett 585:1759-1764.
108. Sopjani M, Foller M, Dreischer P, et al. 2008. Stimulation of eryptosis by cadmium ions. Cell Physiol Biochem 22:245-252.
109. Sugiura H, Yoshida T, Mitobe M, et al. 2010. Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70. Nephrol Dial Transplant 25:60-68.
110. Sugiura H, Yoshida T, Shiohira S, et al. 2012. Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis. Am J Physiol Renal Physiol 302:F1252-F1264.
111. Sugiura H, Yoshida T, Tsuchiya K, et al. 2005. Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant 20:2636-2645. (Pubitemid 41672261)
112. Sun CY, Chang SC, Wu MS. 2012. Suppression of Klotho expres sion by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int 81:640-650.
113. Suyama T, Okada S, Ishijima T, et al. 2012. High phosphorus diet-induced changes in NaPi-IIb phosphate transporter expression in the rat kidney: DNA microarray analysis. PLoS ONE 7: e29483.
114. Tang C, Pathare G, Michael D, et al. 2011. Downregulation of Klotho expression by dehydration. Am J Physiol Renal Physiol 301:F745-F750.
115. Torres PU, Prie D, Molina-Bletry V, et al. 2007. Klotho: An anti-aging protein involved in mineral and vitamin D metabolism. Kidney Int 71:730-737. (Pubitemid 46624027)
116. Tsujikawa H, Kurotaki Y, Fujimori T, et al. 2003. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 17:2393-2403. (Pubitemid 37542205)
117. Urakawa I, Yamazaki Y, Shimada T, et al. 2006. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770-774. (Pubitemid 44949607)
118. Utsugi T, Ohno T, Ohyama Y, et al. 2000. Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging. Metabolism 49:1118-1123.
119. Villa-Bellosta R, Sorribas V. 2010. Compensatory regulation of the sodium/phosphate cotransporters NaPi-IIc (SCL34A3) and Pit-2 (SLC20A2) during Pi deprivation and acidosis. Pflugers Arch 459:499-508.
120. Voormolen N, Noordzij M, Grootendorst DC, et al. 2007. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22:2909-2916. (Pubitemid 350093423)
121. Wang Y, Kuro O, Sun Z. 2012. Klotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP-PKA pathway. Aging Cell 11(3):410-417.
122. Wang Y, Sun Z. 2009a. Current understanding of klotho. Ageing Res Rev 8:43-51.
123. Wang Y, Sun Z. 2009b. Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 54:810-817.
124. Watanabe, et al. 2012. p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int 83(4):582-592.
125. Wolf I, Levanon-Cohen S, Bose S, et al. 2008. Klotho: A tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 27:7094-7105.
126. Woudenberg-Vrenken TE, van der Eerden BC, van der Kemp AW, et al. 2012. Characterization of vitamin D-deficient klotho-/-mice: do increased levels of serum 1, 25 (OH)2D3 cause disturbed calcium and phosphate homeostasis in klotho-/-mice? Nephrol Dial Transplant 27(11):4061-4068.
127. Wu S, Zhou F, Zhang Z, et al. 2011. Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins. FEBS J 278:941-954.
128. Xie B, Zhou J, Shu G, et al. 2013. Restoration of klotho gene expression induces apoptosis and autophagy in gastric cancer cells: Tumor suppressive role of klotho in gastric cancer. Cancer Cell Int 13:18.
129. Xu H, Bai L, Collins JF, et al. 1999. Molecular cloning, functional characterization, tissue distribution, and chromosomal localization of a human, small intestinal sodium-phosphate (Na+-Pi) transporter (SLC34A2). Genomics 62:281-284. (Pubitemid 30053944)
130. Yamamoto M, Clark JD, Pastor JV, et al. 2005. Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem 280:38029-38034. (Pubitemid 41642417)
131. Yoshida T, Fujimori T, Nabeshima Y. 2002. Mediation of unusually high concentrations of 1, 25-dihydroxyvitamin D in homo-zygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Endocrinology 143:683-689. (Pubitemid 34107224)
132. Zacchia M, Capasso G. 2011. Dehydration: A new modulator of klotho expression. Am J Physiol Renal Physiol 301:F743-F744.
133. Zhao N, Tenenhouse HS. 2000. Npt2 gene disruption confers resistance to the inhibitory action of parathyroid hormone on renal sodium-phosphate cotransport. Endocrinology 141:2159-2165. (Pubitemid 32274370)
134. Zhu Y, Xu L, Zhang J, et al. 2013. Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3beta/Snail signaling in renal cell carcinoma. Cancer Sci 104:663-671.